Modulation of microRNAs in hypertension-induced arterial remodeling through the β1 and β3-adrenoreceptor pathways (Q44931728)

7 December 2017

Modulation of microRNAs in hypertension-induced arterial remodeling through the β1 and β3-adrenoreceptor pathways (English)

1 reference

7 December 2017

1 reference

Shukuan Ling

1

1 reference

7 December 2017

Manjyot Nanhwan

2

1 reference

7 December 2017

Jinqiao Qian

3

1 reference

7 December 2017

Monica Kodakandla

4

1 reference

7 December 2017

Alexander C Castillo

5

1 reference

7 December 2017

Bejoy Thomas

6

1 reference

7 December 2017

Hongju Liu

7

1 reference

7 December 2017

Yumei Ye

8

1 reference

7 December 2017

24 October 2013

1 reference

Journal of Molecular and Cellular Cardiology

7 December 2017

1 reference

7 December 2017

65

1 reference

7 December 2017

127-136

1 reference

The emerging role of microRNAs in cardiac remodeling and heart failure

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-α1C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Epigenetic modifications in cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

MicroRNAs play an essential role in the development of cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Silencing of microRNAs in vivo with 'antagomirs'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Nebivolol and endothelium dysfunction in salt-sensitive Dahl rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Effect of miR-23 on oxidant-induced injury in human retinal pigment epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Molecular mechanism underlying Akt activation in zinc-induced cardioprotection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle: implications on decreased myocardial protection in diabetic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Altered microRNA expression in human heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Dietary iron restriction prevents hypertensive cardiovascular remodeling in Dahl salt-sensitive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

TGFβ-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

7 January 2021

MicroRNAs and fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Cardiac overexpression of insulin-like growth factor 1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction but not hypertrophy: Roles of Akt, mTOR, GSK3beta, and PTEN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

Deprenyl prevents MPP(+)-induced oxidative damage in PC12 cells by the upregulation of Nrf2-mediated NQO1 expression through the activation of PI3K/Akt and Erk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.10.003

10.1016/J.YJMCC.2013.10.003

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference